Sign In

Study

Multi-panel Gene Mutation Testing and Targeted Therapy -STRATA Program

Identify KPNC patients with metastatic/incurable cancer for testing of tumors by next generation sequencing (NGS). NGS screening protocol is aligned to a portfolio of pharma-sponsored therapeutic protocols open now or theoretically open in the future, in addition to treatment off study or on NCI or non-STRATA trials.
Investigator: Habel, Laurel
Funder: The Permanente Medical Group